Table 2.
Model 1 | Model 2 | Model 3 | ||||||
---|---|---|---|---|---|---|---|---|
HR | 95% CI | HR | 95% CI | HR | 95% CI | |||
Age (each year increment) | 1.10 | (1.10, 1.10) | 1.10 | (1.10,1.10) | 1.10 | (1.09, 1.10) | ||
Ethnicity | White | 1.00 | 1.00 | 1.00 | ||||
Black | 1.26 | (1.23, 1.30) | 1.28 | (1.25,1.32) | 1.25 | (1.21, 1.28) | ||
Hispanic | 0.87 | (0.82, 0.93) | 0.87 | (0.82, 0.93) | 0.87 | (0.82, 0.93) | ||
Other/Unknown | 0.81 | (0.78, 0.84) | 0.82 | (0.79, 0.85) | 0.80 | (0.77, 0.83) | ||
Men without cancer | 1.00 | 1.00 | 1.00 | |||||
Prostate cancer stage: | ||||||||
1 | 1.01 | (0.98, 1.03) | ||||||
2 | 1.09 | (1.06, 1.11) | ||||||
3 | 1.28 | (1.23, 1.33) | ||||||
4 | 3.93 | (3.80, 4.06) | ||||||
Unknown | 1.50 | (1.45, 1.55) | ||||||
Grade | low/mod grade | 1.05 | (1.03, 1.07) | |||||
poor/undef grade | 1.71 | (1.67, 1.76) | ||||||
unknown grade | 1.70 | (1.65, 1.76) | ||||||
Stage & Grade | ||||||||
Stage 1 | low/mod grade | 0.96 | (0.93, 0.99) | |||||
Stage 2 | low/mod grade | 0.99 | (0.97, 1.02) | |||||
Stage 3 | low/mod grade | 1.07 | (1.01, 1.13) | |||||
Stage 4 | low/mod grade | 2.71 | (2.57, 2.87) | |||||
Stage 1 | poor/undef grade | 1.32 | (1.25, 1.40) | |||||
Stage 2 | poor/undef grade | 1.41 | (1.36, 1.45) | |||||
Stage 3 | poor/undef grade | 1.61 | (1.52, 1.71) | |||||
Stage 4 | poor/undef grade | 4.73 | (4.53, 4.95) | |||||
Comorbidity* | Heart attack | 1.09 | (1.03, 1.15) | 1.09 | (1.03, 1.15) | 1.09 | (1.03, 1.15) | |
Congestive heart failure | 2.28 | (2.21, 2.36) | 2.28 | (2.21, 2.36) | 2.27 | (2.19, 2.34) | ||
Peripheral Vascular Disease | 1.47 | (1.40, 1.54) | 1.47 | (1.40, 1.54) | 1.47 | (1.40, 1.54) | ||
Stroke | 1.50 | (1.45, 1.56) | 1.50 | (1.45, 1.56) | 1.51 | (1.45, 1.56) | ||
COPD | 1.67 | (1.62, 1.71) | 1.65 | (1.60, 1.69) | 1.67 | (1.63, 1.72) | ||
Diabetes | 1.47 | (1.43, 1.51) | 1.46 | (1.43, 1.50) | 1.47 | (1.43, 1.51) |
COPD = chronic obstructive pulmonary disease.